December 4, 2010 | Filed under: Health,News | Posted by:
Adding the intravenous bone drug Zometa to chemotherapy improves survival in patients with the blood cancer multiple myeloma, new research from the U.K. shows.
Posted by
on December 4, 2010. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can leave a response or trackback to this entry
Posted by
on December 4, 2010. Filed under